Oxford Immune Algorithmics

COVID-19 response
In response to the COVID-19 outbreak, we are offering Algocyte®, our rapid blood testing AI technology, to any NHS and health organisation that needs help monitoring the health and immune system of non-COVID-19 patients, at a highly subsidised cost.

Oxford Immune Algorithmics (OIA) is an award-winning biotech company incubated by the University of Oxford which builds technology to move medicine away from its reliance on population-wide symptom pattern matching and toward individual causal diagnostics.

Based on model-driven machine learning, OIA’s technology has the capacity to learn from each user’s immune system, enabling patients and doctors to take more timely and better-informed health decisions.

OIA's platform expands current trends in telemedicine, moving from online medical appointments to smart remote blood testing solutions for immune health monitoring.

The OIA team consists of a group of professionals with advanced degrees in science and medicine. Affiliated with OIA and the universities of Oxford and Cambridge and the Karolinska Institute, the team has published more than 200 papers in top-ranked journals in the areas of AI and immunology.

CE compliant under the European Medical Devices Directive UK MHRA Registration No. 09450
Harmonised ISO 13485, ISO 14971/DCB0129
Patents pending GB1918950.5 and GB1918948.9

Pandemic-ready

Algocyte® is particularly useful to vulnerable patients who may put themselves at risk of infection (e.g. COVID-19) when visiting hospitals or when forced to delay their treatment because they cannot be properly monitored before or after an intervention.

A world free of preventable diseases

The mission of Algocyte® is to help transform healthcare from a discipline that is heavily based upon statistical symptom pattern-matching into one centred on personal patient model-driven causal early diagnosis by exploiting the cutting-edge research on immunology, causality in cell biology, and biological complexity that our team has pioneered at some of the world's best research universities.

Read the feedback from patients and doctors Why Use Algocyte?

Algocyte® is a medically-driven solution that exploits the power of responsible AI to help doctors to remotely monitor the health and immune system of their patients who can test themselves and record their health information safely at home.

Algocyte's features are proven to be of even greater vital importance in the context of the COVID-19 pandemic:

Remote blood testing and analytics for a wide range of patient groups (e.g. haematology, oncology, peri-operative),
smart health monitoring & remote symptom tracking for decision support,
patient triage based on test results,
comparative analysis of treatment/drug response and effectiveness against previous courses, and
alerts based on patients' condition profiles and adaptive personalised baselines.

AI can help make medicine more human by giving doctors the gift of time.

Algocyte® relieves clinicians of time-consuming tasks, of critical importance when dealing with large backlogs inherited from shortage of medical staff or the pandemic emergency. It also enables clinicians to deliver regular contact and care, and healthcare organisations to reduce pressure on their limited resources.

Request more information or a demonstration

Screenshots of Algocyte, a full rapid remote blood testing end-to-end solution that includes an app (also desktop available) with
two-way meaningful communication capabilities between patient and doctor matching symptoms and adverse effects to tests also performed with Algocyte at home.

Bridging the academy & industry

With over two thousand members, our AI meetup groups in the UK are among the largest in their respective cities and demonstrate our commitment to connecting the academic and industrial communities and bringing responsible AI to healthcare: